NPI registry status
Active
2026 NPPES data Ophthalmic Plastic and Reconstructive Surgery Physician NPI 1891259420 MD
Verify on CMS → Soheab Ugradar, MD
Ophthalmic Plastic and Reconstructive Surgery Physician in Los Angeles, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 290 in Ophthalmic Plastic and Reconstructive Surgery Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
592
Medicare Part D claims · 231 beneficiaries · Ophthalmic Plastic and Reconstructive Surgery Physician avg: 624
Generic prescribing
27%
generic claims · 73% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
74.6/100
▼ 9 pts below national avg 83.1 · Mid-tier
Industry payments
$21.6K
3 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Soheab Ugradar, MD reported a CMS MIPS final score of 74.6/100 - below the 83.1 national average - and filed 592 Medicare Part D claims in 2023.
- 74.6/100
- MIPS score · -9 vs avg
- 592
- Part D claims, 2023
- 27%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Soheab Ugradar, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
75 12th percentile higher than 12% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Soheab Ugradar, MD sits
This provider among ophthalmic plastic and reconstructive surgery physician peers
Across the 141 ophthalmic plastic and reconstructive surgery physician providers who report both Medicare Part D prescribing and a MIPS quality score, Soheab Ugradar, MD writes more Part D claims than 54% of them and scores higher on MIPS quality than 13% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one ophthalmic plastic and reconstructive surgery physician peer from a representative sample of 60; the gold marker is Soheab Ugradar, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Soheab Ugradar, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Soheab Ugradar, MD?
Below national averagePrimary specialty
Ophthalmic Plastic and Reconstructive Surgery Physician
Medicare Part D claims
592 5% vs specialty avg
MIPS final score
74.6/100 8.5 pts vs avg
Specialty distribution in California
How Ophthalmic Plastic and Reconstructive Surgery Physician compares to other specialties among California providers
Medicare quality performance, MIPS
Soheab Ugradar, MD's 2023 MIPS final score plotted against the Ophthalmic Plastic and Reconstructive Surgery Physician national average
- MIPS Final Score
- 74.6/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Ophthalmic Plastic and Reconstructive Surgery Physician) - 74.6/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Soheab Ugradar, MD appears in the CMS NPPES registry as an Ophthalmic Plastic and Reconstructive Surgery Physician provider holding MD credentials at 300 STEIN PLAZA, Los Angeles, CA, 90095, with a listed phone of (310) 206-8250. NPI 1891259420 was issued on 01/28/2019.
Medicare Part D records for calendar year 2023 show 592 prescription claims written by this provider, covering 231 Medicare beneficiaries and totaling roughly $657K in drug spend, split 73% brand-name and 27% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 74.6/100 for the 2023 performance year (Quality 85, Cost 30.2), compared with the national average of 83.1.
Ophthalmic Plastic and Reconstructive Surgery Physician is a narrow specialty nationwide, with 290 enrolled providers across 46 states and an average of 624 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1891259420 |
|---|---|
| Specialty | Ophthalmic Plastic and Reconstructive Surgery Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 01/28/2019 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
74.5602
Final Score
Avg: 83.1
85.0247
Quality
30.176
Cost
100
Promoting Interoperability
Reporting: Group practice
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Soheab Ugradar, MD. Source: openpaymentsdata.cms.gov.
Total received
$21.6K
Largest payer
Amgen Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Soheab Ugradar, MD. To verify Soheab Ugradar, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Soheab Ugradar, MD - brand share 73.0%
Ophthalmic Plastic and Reconstructive Surgery Physician average
73% brand-name claims vs 27% generic, on 592 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
592
Total Claims
$657K
Total Drug Cost
231
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 732
- Total Day Supply
- 19,398
- Brand vs Generic
- 73% brand / 27% generic
- Brand Drug Cost
- $649K
- Generic Drug Cost
- $8K
- Antibiotic Claims
- 29
Patient Demographics
- Average Patient Age
- 73.8 years
- Avg HCC Risk Score
- 1.42
- Gender Split
- 71% female / 29% male
- Age Distribution
- <65: 15, 65-74: 119, 75-84: 74, 85+: 23
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Soheab Ugradar, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Restasis
Restasis
173 claims
- Xiidra
Xiidra
72 claims
- Cyclosporine 54
Cyclosporine
54 claims
- Erythromycin 43
Erythromycin
43 claims
- Latanoprost 38
Latanoprost
38 claims
- Prednisolone Acetate 26
Prednisolone Acetate
26 claims
- Restasis Multidose 25
Restasis Multidose
25 claims
- Doxycycline Monohy… 16
Doxycycline Monohydrate
16 claims
| Drug | Claims |
|---|---|
| Restasis Cyclosporine | 173 |
| Xiidra Lifitegrast | 72 |
| Cyclosporine | 54 |
| Erythromycin Erythromycin Base | 43 |
| Latanoprost | 38 |
| Prednisolone Acetate | 26 |
| Restasis Multidose Cyclosporine | 25 |
| Doxycycline Monohydrate | 16 |
| Timolol Maleate | 16 |
| Lumigan Bimatoprost | 15 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Ophthalmic Plastic and Reconstructive Surgery Physician in CA →
All providers in California →
Compare specialties →
Ophthalmic Plastic and Reconstructive Surgery Physician Overview
How Soheab Ugradar, MD fits within the Ophthalmic Plastic and Reconstructive Surgery Physician landscape nationally.
290
Ophthalmic Plastic and Reconstructive Surgery Physician Providers in US
46
States with Ophthalmic Plastic and Reconstructive Surgery Physician
624
Avg Claims per Provider
Soheab Ugradar, MD's 592 claims are below the specialty average of 624.
Nearby Ophthalmic Plastic and Reconstructive Surgery Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Ugradar.
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the California medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Ophthalmic Plastic and Reconstructive Surgery Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore California
Frequently Asked Questions
What is Soheab Ugradar, MD's specialty? ▼
Soheab Ugradar, MD specializes in Ophthalmic Plastic and Reconstructive Surgery Physician and practices in Los Angeles, California. Credentials: MD.
How much does Soheab Ugradar, MD prescribe under Medicare Part D? ▼
In 2023, Soheab Ugradar, MD wrote 592 Medicare Part D claims totaling $657K in drug costs for 231 beneficiaries.
What is Soheab Ugradar, MD's Medicare quality score? ▼
Soheab Ugradar, MD has a CMS MIPS Final Score of 74.6/100 (Quality: 85, Cost: 30.2). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Soheab Ugradar, MD located? ▼
Soheab Ugradar, MD is located at 300 STEIN PLAZA, Los Angeles, CA, 90095. Phone: (310) 206-8250.
What is Soheab Ugradar, MD's NPI number? ▼
Soheab Ugradar, MD's National Provider Identifier (NPI) is 1891259420, issued on 01/28/2019.
Does Soheab Ugradar, MD prescribe more brand-name or generic drugs? ▼
Soheab Ugradar, MD's prescribing is 73% brand-name and 27% generic drugs by claim count, with $649K in brand drug costs.
How many Ophthalmic Plastic and Reconstructive Surgery Physician providers are there in the US? ▼
There are 290 Ophthalmic Plastic and Reconstructive Surgery Physician providers across 46 states in the US. The average Ophthalmic Plastic and Reconstructive Surgery Physician provider writes 624 Medicare Part D claims per year.
What drugs does Soheab Ugradar, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Soheab Ugradar, MD's most frequently prescribed drugs include Restasis, Xiidra, Cyclosporine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Soheab Ugradar, MD accept Medicare? ▼
Soheab Ugradar, MD appears in CMS Medicare data with 592 Part D claims and 231 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Soheab Ugradar, MD's credentials? ▼
Soheab Ugradar, MD's NPI is 1891259420 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.